Published in Br J Clin Pharmacol on February 01, 1993
The physiological action of beta-iminazolylethylamine. J Physiol (1910) 43.41
Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax (1984) 2.20
In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole. Mol Pharmacol (1982) 1.48
Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol (1984) 1.44
H1-receptor antagonists: clinical pharmacology and therapeutics. J Allergy Clin Immunol (1989) 1.24
Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther (1978) 0.99
Pharmacology of the specific histamine H1-antagonist astemizole. Arzneimittelforschung (1983) 0.95
Comparison of the suppressive effect of astemizole, terfenadine, and hydroxyzine on histamine-induced wheals and flares in humans. J Allergy Clin Immunol (1986) 0.86
How to do it. Get patients' consent to enter clinical trials. BMJ (1995) 3.76
T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol (1996) 2.92
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J (2000) 2.42
Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler. BMJ (1992) 2.25
Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax (1984) 2.20
Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1990) 2.14
Interleukin 4 is localized to and released by human mast cells. J Exp Med (1992) 2.00
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax (2001) 1.95
Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem (1993) 1.79
Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol (1993) 1.78
What's new about hay fever? Br Med J (Clin Res Ed) (1985) 1.76
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. Br Med J (Clin Res Ed) (1984) 1.73
Airway wall remodelling in asthma. Thorax (1997) 1.65
Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med (1997) 1.64
Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet (1991) 1.59
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma. Eur Respir J (1999) 1.58
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Depression, mood state, and back pain during microgravity simulated by bed rest. Psychosom Med (2001) 1.55
A controlled evaluation of token economy procedures with chronic schizophrenic patients. Behav Res Ther (1977) 1.53
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50
The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis (1991) 1.49
Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol (1984) 1.44
Topically applied tetracaine, adrenalin, and cocaine in the repair of traumatic wounds of the head and neck. Otolaryngol Head Neck Surg (1989) 1.42
Thermal stabilities of globular proteins. Biochemistry (1989) 1.36
BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy (2008) 1.29
Genome-wide association study to identify genetic determinants of severe asthma. Thorax (2012) 1.27
Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis (1985) 1.25
Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest (1994) 1.22
Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J (1992) 1.20
Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax (2000) 1.20
A mutant baculovirus with a temperature-sensitive IE-1 transregulatory protein. J Virol (1994) 1.16
Heterogeneity of human mast cells based on cytokine content. J Immunol (1995) 1.15
Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol (2001) 1.13
Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol (2001) 1.11
Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis (1992) 1.11
Pharmacotherapy and airway remodelling in asthma? Thorax (2003) 1.11
Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Respir Crit Care Med (1995) 1.10
Bronchoconstriction in response to ipratropium bromide. Br Med J (Clin Res Ed) (1983) 1.09
The control of allergens of dust mites and domestic pets: a position paper. Clin Exp Allergy (1992) 1.09
Comparative nasal effects of bradykinin, kallidin and [Des-Arg9]-bradykinin in atopic rhinitic and normal volunteers. J Physiol (1991) 1.06
The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol (1992) 1.05
New insights into airway inflammation by endobronchial biopsy. Am Rev Respir Dis (1992) 1.02
Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. Eur Respir J (2007) 1.02
Remodelling of the upper airways in allergic rhinitis: is it a feature of the disease? Clin Exp Allergy (2003) 1.02
Intercellular adhesion molecule-1 (ICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in the bronchial mucosa of normal and asthmatic subjects. Eur Respir J (1992) 1.01
Cinnarizine in the treatment of chronic asthma. Br J Clin Pharmacol (1979) 1.01
Leukocyte recruitment after local endobronchial allergen challenge in asthma. Relationship to procedure and to airway interleukin-8 release. Am J Respir Crit Care Med (1996) 1.01
A comparison of spinal quantitative computed tomography with dual energy X-ray absorptiometry in European women with vertebral and nonvertebral fractures. Calcif Tissue Int (2001) 1.01
Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma. Thorax (2004) 0.98
Geographical variation in the prevalence of sensitization to common aeroallergens in adults: the GA(2) LEN survey. Allergy (2014) 0.97
A method for evaluating therapy for hay fever. A comparison of four treatments. Clin Allergy (1983) 0.97
TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy (1995) 0.96
Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms. Thorax (1996) 0.96
The assessment of an antimycotic in the day to day functioning of venereology clinics. Br J Clin Pract (1978) 0.95
The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol (1986) 0.93
Exhaled nitric oxide; relationship to clinicophysiological markers of asthma severity. Respir Med (1998) 0.93
Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med (1994) 0.92
Airway effects of local challenge with hypertonic saline in exercise-induced asthma. Am J Respir Crit Care Med (1994) 0.92
Osteopontin is expressed and functional in human eosinophils. Allergy (2009) 0.92
Transforming growth factor-beta in allergic inflammatory disease of the upper airways: friend or foe? Clin Exp Allergy (2009) 0.90
Allergic rhinitis: past, present and the future. Clin Otolaryngol Allied Sci (2003) 0.90
Relationship between mediator release from human lung mast cells in vitro and in vivo. Int Arch Allergy Appl Immunol (1985) 0.90
Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med (1995) 0.89
Mechanisms and mediators of nasal symptoms in non-allergic rhinitis. Clin Exp Allergy (2008) 0.88
Nasal effects of bradykinin and capsaicin: influence on plasma protein leakage and role of sensory neurons. J Appl Physiol (1985) (1992) 0.88
The antihistamines of the nineties. Clin Rev Allergy (1993) 0.88
Inflammatory and T-cell profile of asthmatic airways 6 hours after local allergen provocation. Am J Respir Crit Care Med (1996) 0.87
Early changes in T lymphocytes recovered by bronchoalveolar lavage after local allergen challenge of asthmatic airways. Am Rev Respir Dis (1992) 0.87
The relationship between atopic status and IL-10 nasal lavage levels in the acute and persistent inflammatory response to upper respiratory tract infection. Am J Respir Crit Care Med (2001) 0.87
Co-localization of immunoreactive transforming growth factor-beta 1 and decorin in bronchial biopsies from asthmatic and normal subjects. J Pathol (1998) 0.86
Genetic and environmental influences on airway inflammation in asthma. Int Arch Allergy Immunol (1995) 0.86
Astemizole and other H1-antihistaminic drug treatment of asthma. J Allergy Clin Immunol (1985) 0.86
Exercise and isocapnic hyperventilation-induced bronchoconstriction in asthma: relevance of circulating basophils to measurements of plasma histamine. J Allergy Clin Immunol (1984) 0.85
Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation. Thorax (1993) 0.85
Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. Eur Respir J (1995) 0.84
Airway endothelin levels in asthma: influence of endobronchial allergen challenge and maintenance corticosteroid therapy. Eur Respir J (1997) 0.84
Clinical profile of astemizole. A survey of 50 double-blind trials. Ann Allergy (1987) 0.84
Effect of inhaled frusemide on responses of airways to bradykinin and adenosine 5'-monophosphate in asthma. Thorax (1994) 0.84
The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release. Clin Exp Allergy (2005) 0.84
Nitric oxide and the respiratory system in health and disease. Respir Med (1998) 0.84
Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy (2014) 0.83
Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J (1993) 0.83
Safety aspects of local endobronchial allergen challenge in asthmatic patients. Am J Respir Crit Care Med (1996) 0.83
Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. Int Arch Allergy Immunol (2001) 0.83
Exercise, asthma, and mast cells. Lancet (1983) 0.83
Preliminary study of the cellular characteristics of primary bronchial fibroblasts in patients with asthma: expression of alpha-smooth muscle actin, fibronectin containing extra type III domain A, and smoothelin. J Investig Allergol Clin Immunol (2012) 0.83
Effect of inhaled platelet-activating factor on bronchial inflammation in atopic non-asthmatic subjects. Int Arch Allergy Immunol (1992) 0.82
Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol (1997) 0.82
Cinnarizine in the treatment of peripheral vascular disease: mechanisms related to its clinical action. Proc R Soc Med (1977) 0.82
Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion. Br Med J (Clin Res Ed) (1986) 0.81
Cytokine production by cell cultures from bronchial subepithelial myofibroblasts. J Pathol (1996) 0.81
The T cell and the airway's fibrotic response in asthma. Chest (1993) 0.81
Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism. Clin Otolaryngol Allied Sci (1996) 0.81
Pathology of rhinitis and bronchial asthma. Clin Exp Allergy (1996) 0.81
Effects of short-term exposure to 0.2 ppm ozone on biomarkers of inflammation in sputum, exhaled nitric oxide, and lung function in subjects with mild atopic asthma. J Occup Environ Med (2000) 0.80